Thursday, July 9, 2026

pharma · severe uncontrolled asthma · mild to moderate asthma, Chronic Obstructive Pulmonary Disease (COPD) · GENB

Generate Biomedicines

News and analysis for Generate Biomedicines on NovaPharmaNews — regulatory, clinical, and market coverage.

Somerville, USA HQ
325 Employees
Public company Type
GENB · NYSE Ticker
Company details
Status
Public
HQ
Somerville, USA
Employees
325
Programs
8
Drugs
7
Patents
1
Intelligence · Coverage

News & analysis

NovaPharmaNews articles mentioning Generate Biomedicines — regulatory, clinical, and market coverage.

News and analysis for Generate Biomedicines on NovaPharmaNews — regulatory, clinical, and market coverage.

No coverage yet

We have not published news or analysis mentioning Generate Biomedicines yet.

Back to company overview →